J. Goldman & CO LP Rapt Therapeutics, Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $405,177 - $931,592	-39,491 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $196,836 - $465,144	-11,565 Reduced 22.65%	39,491 $868,000
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $1.51 Million - $2.02 Million	51,056 New	51,056 $1.88 Million

9.3M

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $881M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.